Overview
Financials
Revenue history (in k)
Filing timeliness
No financial statement for 2024 – the filing deadline has passed. 4 of 6 financial statements were filed late (the longest delay 1047 days for 2018).
- 2024not filed
- 202316/07/2024
- 202230/06/2023
- 202128/06/2022
- 202023/05/2022
- 201908/03/2022
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2023.
Results vs industry
Industry
Authorized Representatives
Manner of representation
In the case of a multi-member management board, each member of the management board may independently make declarations of will on behalf of the company in property matters, provided that, in the case of incurring liabilities or disposing of a right with a value exceeding PLN 50,000.00 (fifty thousand zloty), the company is represented jointly by two members of the management board or by a member of the management board jointly with a commercial proxy. In the case of a multi-member management board, each member of the management board may independently make declarations of will on behalf of the company in non-property matters.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Daniel Adam Dąbrowskiage 46 | 546 | $14,748.78 | 33.3333% |
Zdzisław Olchowikage 54 | 546 | $14,748.78 | 33.3333% |
Marek Waldemar Pałysaage 52 | 546 | $14,748.78 | 33.3333% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2015-08-01.
16 2490 0005 0000 4520 7294 0627- 73 2490 0005 0000 4612 1524 5473
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Natur DayS.A. | $680,635.59 | naturday.pl | ||
| Biotriosp. z o.o. | $453,662.22 | biotrio.pl | ||
| Nature's Voicesp. z o.o. | $181,977.76 | naturesvoice.eu | ||
| Pexon Polandsp. z o.o. | $122,615.96 | pexon.pl | ||
| Munar PharmaS.A. | $85,649.72 | munar.pl | ||
| Bioresearch PharmaS.A. | $21,432.15 | bioresearchpharma.com | ||
| Sanford Biotechsp. z o.o. | $2,586.64 | sanfordbiotech.com | ||
| Cefeasp. z o.o. | $294.66 | cefea.pl | ||
| Auxilius PharmaS.A. | $0.83 | auxiliuspharma.com | ||
| Grupa FinepharmS.A. | – | finepharm.pl |
Change history
| Date | Event | |
|---|---|---|
| 2023-12-07 | Address change (Ul. Lekka 3/U4, 01-910, Warszawa → Ul. Gdańska 49a, 01-633, Warszawa) | |
| 2022-10-27 | Address change (Ul. Szlachecka 33, 05-090, Dawidy Bankowe → Ul. Lekka 3/U4, 01-910, Warszawa) | |
| 2019-05-22 | Address change (28, 09-164, Dzierzążnia → Ul. Szlachecka 33, 05-090, Dawidy Bankowe) | |
| 2017-10-10 | Address change (Ul. Poziomkowa 2, 20-224, Lublin → 28, 09-164, Dzierzążnia) | |
| 2016-03-18 | Share capital change (18,800.00 PLN → 163,800.00 PLN) |
FAQ
Last updated: 2026-04-13